← Back to headlines
Novo Nordisk’s Torrid Week Erases Last of Wegovy-Fueled Gains
Novo Nordisk experienced a challenging week, with its stock losing all gains previously attributed to the success of its drug, Wegovy.
27 Feb, 10:56 — 27 Feb, 10:56
Sources
Showing 1 of 1 sources
